Foundry Partners, LLC Eagle Pharmaceuticals, Inc. Transaction History

Foundry Partners, LLC

$1.95 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	BUY	$44.58 - $52.6 $1.01 Million - $1.19 Million	22,660 Added 36.75%	84,325 $4.17 Million
Q4 2021 Jan 26, 2022	SELL	$45.82 - $56.9 $92,556 - $114,938	-2,020 Reduced 3.17%	61,665 $3.14 Million
Q3 2021 Oct 14, 2021	SELL	$43.79 - $55.78 $126,991 - $161,762	-2,900 Reduced 4.36%	63,685 $3.55 Million
Q2 2021 Jul 23, 2021	SELL	$36.86 - $44.5 $449,175 - $542,277	-12,186 Reduced 15.47%	66,585 $2.85 Million
Q1 2021 May 12, 2021	SELL	$40.32 - $50.97 $117,129 - $148,067	-2,905 Reduced 3.56%	78,771 $3.29 Million
Q4 2020 Feb 04, 2021	BUY	$41.72 - $51.34 $185,445 - $228,206	4,445 Added 5.76%	81,676 $3.8 Million
Q3 2020 Oct 23, 2020	BUY	$37.02 - $51.28 $79,889 - $110,662	2,158 Added 2.87%	77,231 $3.28 Million
Q2 2020 Aug 03, 2020	SELL	$43.24 - $55.02 $410,952 - $522,910	-9,504 Reduced 11.24%	75,073 $3.6 Million
Q1 2020 May 08, 2020	BUY	$34.37 - $60.07 $488,741 - $854,195	14,220 Added 20.21%	84,577 $3.89 Million
Q4 2019 Feb 10, 2020	SELL	$54.32 - $64.31 $315,218 - $373,190	-5,803 Reduced 7.62%	70,357 $4.23 Million
Q3 2019 Oct 23, 2019	BUY	$53.25 - $59.98 $147,768 - $166,444	2,775 Added 3.78%	76,160 $4.31 Million
Q2 2019 Jul 18, 2019	BUY	$46.61 - $58.45 $3.07 Million - $3.85 Million	65,785 Added 865.59%	73,385 $4.09 Million
Q1 2019 Apr 22, 2019	BUY	$38.66 - $51.82 $90,850 - $121,777	2,350 Added 44.76%	7,600 $384,000
Q4 2018 Jan 10, 2019	SELL	$36.72 - $67.73 $86,292 - $159,165	-2,350 Reduced 30.92%	5,250 $364,000
Q4 2018 Jan 10, 2019	BUY	$36.72 - $67.73 $86,292 - $159,165	2,350 Added 44.76%	7,600 $306,000
Q3 2018 Oct 17, 2018	SELL	$66.65 - $83.86 $27,659 - $34,801	-415 Reduced 7.33%	5,250 $364,000
Q1 2018 May 16, 2018	SELL	$52.16 - $66.86 $86,064 - $110,319	-1,650 Reduced 22.56%	5,665 $298,000
Q4 2017 Jan 25, 2018	BUY	$49.6 - $60.87 $176,824 - $217,001	3,565 Added 95.07%	7,315 $391,000
Q3 2017 Oct 31, 2017	BUY	$46.62 - $60.36 $174,825 - $226,350	3,750	3,750 $224,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Account